Evidence map›Paper›PMID 38297098›Full record

ArticleEMBO molecular medicine2024

Infected erythrocytes and plasma proteomics reveal a specific protein signature of severe malaria.

Jeremy Fraering, Virginie Salnot, Emilie-Fleur Gautier, Sem Ezinmegnon, Nicolas Argy, Katell Peoc'h, Hana Manceau, Jules Alao, François Guillonneau, Florence Migot-Nabias and 3 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Serum Proteomics Reveals Systemic Responses inPathogens (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 4 countries.

Jeremy FraeringUMR261 MERIT, Université Paris Cité, IRD, F-75006, Paris, France.
Virginie SalnotPlateforme Proteom'IC, Institut Cochin, Université Paris Cité, INSERM U-1016, CNRS UMR8104, Paris, France.
Emilie-Fleur GautierPlateforme Proteom'IC, Institut Cochin, Université Paris Cité, INSERM U-1016, CNRS UMR8104, Paris, France.
Sem EzinmegnonGroupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.
Nicolas ArgyUMR261 MERIT, Université Paris Cité, IRD, F-75006, Paris, France.
Katell Peoc'hLaboratoire d'Excellence GR-Ex, F-75015, Paris, France.
Hana ManceauLaboratoire d'Excellence GR-Ex, F-75015, Paris, France.ORCID http://orcid.org/0000-0003-4158-0964
Jules AlaoService de Pédiatrie, Centre Hospitalier Universitaire de la Mère et de l'Enfant-Lagune de Cotonou, Cotonou, Benin.
François GuillonneauPlateforme Proteom'IC, Institut Cochin, Université Paris Cité, INSERM U-1016, CNRS UMR8104, Paris, France.ORCID http://orcid.org/0000-0003-1484-4696
Florence Migot-NabiasUMR261 MERIT, Université Paris Cité, IRD, F-75006, Paris, France.ORCID http://orcid.org/0000-0001-9982-594X
Gwladys I Bertin *UMR261 MERIT, Université Paris Cité, IRD, F-75006, Paris, France. gwladys.bertin@ird.fr.ORCID http://orcid.org/0000-0002-2218-9591
Claire Kamaliddin *UMR261 MERIT, Université Paris Cité, IRD, F-75006, Paris, France. claire.kamaliddin@ucalgary.ca.ORCID http://orcid.org/0000-0001-8198-6235
NeuroCM consortium
Université Paris Cité · FRUniversité d'Abomey-Calavi · BJCentre National de la Recherche Scientifique · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRCentre National Hospitalier et Universitaire Hubert Koutoukou MAGA · BJGroupe de Recherche et d’Action sur le Foncier · BFHôpital Mère-Enfant · FRUniversité de Limoges · FRUniversité Toulouse III - Paul Sabatier · FRUniversity of Calgary · CA

Funding

Agence Nationale de la Recherche (ANR) ANR-17-CE17-0001French Minister of Research PhD ScholarshipMerieux 2014
6 · The paper itself

Abstract

Cerebral malaria (CM), the most lethal complication of Plasmodium falciparum severe malaria (SM), remains fatal for 15-25% of affected children despite the availability of treatment. P. falciparum infects and multiplies in erythrocytes, contributing to anemia, parasite sequestration, and inflammation. An unbiased proteomic assessment of infected erythrocytes and plasma samples from 24 Beninese children was performed to study the complex mechanisms underlying CM. A significant down-regulation of proteins from the ubiquitin-proteasome pathway and an up-regulation of the erythroid precursor marker transferrin receptor protein 1 (TFRC) were associated with infected erythrocytes from CM patients. At the plasma level, the samples clustered according to clinical presentation. Significantly, increased levels of the 20S proteasome components were associated with SM. Targeted quantification assays confirmed these findings on a larger cohort (n = 340). These findings suggest that parasites causing CM preferentially infect reticulocytes or erythroblasts and alter their maturation. Importantly, the host plasma proteome serves as a specific signature of SM and presents a remarkable opportunity for developing innovative diagnostic and prognostic biomarkers.

Indexed as

Malaria, CerebralMalaria, FalciparumChildErythrocytesHumansPlasmodium falciparumProteomicsBiomarkersCerebral MalariaLC-MS/MSPlasmodium falciparumRed Blood Cells

Identifiers

PMID38297098
PMCPMC10897182
OpenAlexW4391419801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.